LRMR

#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
2.53
2.69
Rango anual
2.53
6.42
Cambio diario
-5.24%
Variación mensual
-34.11%
Variación en los últimos 6 meses
-48.47%
Cambio anual
-39.33%
Cierres anteriores
2.6 7
Open
2.6 6
Mínimo
2.5 3
Máximo
2.6 9
Ver el calendario completo

Financials

Visión general Informes Estadísticas Documents

2022

Current report, 14 Feb 2022

Larimar Therapeutics, Inc. current report, 14 February 2022
8-K

2021

Annual report, FY2021

Larimar Therapeutics, Inc. annual report, FY2021
10-K

Current report, 12 Nov 2021

Larimar Therapeutics, Inc. current report, 12 November 2021
8-K

Quarterly report, Q3 FY2021

Larimar Therapeutics, Inc. quarterly report, Q3 FY2021
10-Q

Current report, 12 Aug 2021

Larimar Therapeutics, Inc. current report, 12 August 2021
8-K

Current report, 01 Jul 2021

Larimar Therapeutics, Inc. current report, 01 July 2021
8-K

Quarterly report, Q2 FY2021

Larimar Therapeutics, Inc. quarterly report, Q2 FY2021
10-Q

Current report, 14 Jun 2021

Larimar Therapeutics, Inc. current report, 14 June 2021
8-K

Current report, 25 May 2021

Larimar Therapeutics, Inc. current report, 25 May 2021
8-K

Current report, 21 May 2021

Larimar Therapeutics, Inc. current report, 21 May 2021
8-K

Noticias